Sequence variants and the risk of head and neck cancer: Pooled analysis in the INHANCE consortium

Shu Chun Chuang, Antonio Agudo, Wolfgang Ahrens, Devasena Anantharaman, Simone Benhamou, Stefania Boccia, Chu Chen, David I. Conway, Eleonora Fabianova, Richard B. Hayes, Claire M. Healy, Ivana Holcatova, Kristina Kjaerheim, Pagona Lagiou, Philip Lazarus, Tatiana V. Macfarlane, Manoj B. Mahimkar, Dana Mates, Keitaro Matsuo, Franco MerlettiAndres Metspalu, Hal Morgenstern, Joshua Muscat, Gabriella Cadoni, Andrew F. Olshan, Mark Purdue, Heribert Ramroth, Peter Rudnai, Stephen M. Schwartz, Lorenzo Simonato, Elaine M. Smith, Erich M. Sturgis, Neonilia Szeszenia-Dabrowska, Renato Talamini, Peter Thomson, Qingyi Wei, David Zaridze, Zuo Feng Zhang, Ariana Znaor, Paul Brennan, Paolo Boffetta, Mia Hashibe

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Previous molecular epidemiological studies on head and neck cancer have examined various single nucleotide polymorphisms (SNPs), but there are very few documented associations. In the International head and neck cancer epidemiology (INHANCE) consortium, we evaluated associations between SNPs in the metabolism, cell cycle, and DNA repair pathways and the risk of head and neck cancer. We analyzed individual-level pooled data from 14 European, North American, Central American, and Asia case-control studies (5,915 head and neck cancer cases and 10,644 controls) participating in the INHANCE consortium. Unconditional logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for SNP effects, adjusting for age, sex, race, and country. We observed an association between head and neck cancer risk and MGMT Leu84Phe heterozygotes (OR = 0.79, 95% CI = 0.68-0.93), XRCC1 Arg194Trp homozygotes Arg/Arg (OR = 2.3, 95% CI = 1.1-4.7), ADH1B Arg48His homozygotes Arg/Arg (OR = 2.7, 95% CI = 1.9-4.0), ADH1C Ile350Val homozygotes Ile/Ile (OR = 1.2, 95% CI = 1.1-1.4), and the GSTM1 null genotype (OR = 1.1, 95% CI = 1.0-1.2). Among these results, MGMT Leu84Phe, ADH1B Arg48His, ADH1C Ile350Arg, and the GSTM1 null genotype had fairly low false positive report probabilities (<20%). We observed associations between ADH1B Arg48His, ADH1C Ile350Arg, and GSTM1 null genotype and head and neck cancer risk. No functional study currently supports the observed association for MGMT Leu84Phe, and the association with XRCC1 Arg194Trp may be a chance finding.

Original languageEnglish (US)
Article number00013
JournalFrontiers in Oncology
Volume1
Issue numberJUL
DOIs
StatePublished - 2011

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Sequence variants and the risk of head and neck cancer: Pooled analysis in the INHANCE consortium'. Together they form a unique fingerprint.

  • Cite this

    Chuang, S. C., Agudo, A., Ahrens, W., Anantharaman, D., Benhamou, S., Boccia, S., Chen, C., Conway, D. I., Fabianova, E., Hayes, R. B., Healy, C. M., Holcatova, I., Kjaerheim, K., Lagiou, P., Lazarus, P., Macfarlane, T. V., Mahimkar, M. B., Mates, D., Matsuo, K., ... Hashibe, M. (2011). Sequence variants and the risk of head and neck cancer: Pooled analysis in the INHANCE consortium. Frontiers in Oncology, 1(JUL), [00013]. https://doi.org/10.3389/fonc.2011.00013